Suppr超能文献

常染色体显性多囊肾病进展的预测因素。

Predictors of autosomal dominant polycystic kidney disease progression.

作者信息

Schrier Robert W, Brosnahan Godela, Cadnapaphornchai Melissa A, Chonchol Michel, Friend Keith, Gitomer Berenice, Rossetti Sandro

机构信息

Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, Colorado; and

Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, Colorado; and.

出版信息

J Am Soc Nephrol. 2014 Nov;25(11):2399-418. doi: 10.1681/ASN.2013111184. Epub 2014 Jun 12.

Abstract

Autosomal dominant polycystic kidney disease is a genetic disorder associated with substantial variability in its natural course within and between affected families. Understanding predictors for rapid progression of this disease has become increasingly important with the emergence of potential new treatments. This systematic review of the literature since 1988 evaluates factors that may predict and/or effect autosomal dominant polycystic kidney disease progression. Predicting factors associated with early adverse structural and/or functional outcomes are considered. These factors include PKD1 mutation (particularly truncating mutation), men, early onset of hypertension, early and frequent gross hematuria, and among women, three or more pregnancies. Increases in total kidney volume and decreases in GFR and renal blood flow greater than expected for a given age also signify rapid disease progression. Concerning laboratory markers include overt proteinuria, macroalbuminuria, and perhaps, elevated serum copeptin levels in affected adults. These factors and others may help to identify patients with autosomal dominant polycystic kidney disease who are most likely to benefit from early intervention with novel treatments.

摘要

常染色体显性多囊肾病是一种遗传性疾病,在受影响的家族内部和家族之间,其自然病程存在很大差异。随着潜在新疗法的出现,了解该疾病快速进展的预测因素变得越来越重要。本对1988年以来文献的系统综述评估了可能预测和/或影响常染色体显性多囊肾病进展的因素。考虑了与早期不良结构和/或功能结局相关的预测因素。这些因素包括PKD1突变(特别是截短突变)、男性、高血压早发、早期频繁出现肉眼血尿,以及在女性中,三次或更多次怀孕。在特定年龄下,总肾体积增加、肾小球滤过率和肾血流量下降超过预期也表明疾病进展迅速。相关的实验室指标包括显性蛋白尿、大量白蛋白尿,或许还有受影响成年人血清 copeptin 水平升高。这些因素及其他因素可能有助于识别最有可能从新型疗法早期干预中获益的常染色体显性多囊肾病患者。

相似文献

1
Predictors of autosomal dominant polycystic kidney disease progression.常染色体显性多囊肾病进展的预测因素。
J Am Soc Nephrol. 2014 Nov;25(11):2399-418. doi: 10.1681/ASN.2013111184. Epub 2014 Jun 12.
4
Intestinal barrier function declines during polycystic kidney disease progression.在多囊肾病进展过程中,肠道屏障功能会下降。
Am J Physiol Renal Physiol. 2025 Feb 1;328(2):F218-F229. doi: 10.1152/ajprenal.00058.2024. Epub 2024 Dec 18.
8
Kidney stone formation in a novel murine model of polycystic kidney disease.多囊肾病新型小鼠模型中的肾结石形成。
Am J Physiol Renal Physiol. 2022 Jul 1;323(1):F59-F68. doi: 10.1152/ajprenal.00165.2021. Epub 2022 Mar 28.
9
The impact of maternal obesity on polycystic kidney disease progression in a mouse model.母体肥胖对小鼠模型中多囊肾病进展的影响。
Am J Physiol Renal Physiol. 2025 Mar 1;328(3):F316-F327. doi: 10.1152/ajprenal.00227.2024. Epub 2025 Feb 5.

引用本文的文献

本文引用的文献

5
Type of PKD1 mutation influences renal outcome in ADPKD.PKD1 突变类型影响 ADPKD 的肾脏结局。
J Am Soc Nephrol. 2013 May;24(6):1006-13. doi: 10.1681/ASN.2012070650. Epub 2013 Feb 21.
6
The medicinal use of water in renal disease.水在肾病中的药用。
Kidney Int. 2013 Jul;84(1):45-53. doi: 10.1038/ki.2013.23. Epub 2013 Feb 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验